Vaibhav B. Shah The University of New South Wales

Home

Archive

About Us

Christopher Aiken Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, USA
1 protocol

Alessandro Didonna East Carolina University
73 protocols

Anca Savulescu University of Cape Town
24 protocols

Antoine de Morree Stanford university
37 protocols

Chiara Ambrogio University of Turin
68 protocols

Reviewer

Vaibhav B. Shah

Research scientist, The University of New South Wales

Research focus

Microbiology
virology, proteomics, molecular biology

1 Author merit
Reviewer merit
Editor merit

Education

Ph.D., The Ohio State University, 2009

1 Protocol published

Cell Fractionation and Quantitative Analysis of HIV-1 Reverse Transcription in Target Cells

Authors: Vaibhav B Shah and Christopher Aiken, date: 10/20/2013, view: 9540, Q&A: 0

This is a protocol to detect HIV-1 reverse transcription products in cytoplasmic and nuclear fractions of cells infected with VSV-G-pseudotyped envelope-defective HIV-1. This protocol can also be extended to HIV-1 with regular envelope.

More >

20 Protocols reviewed

Normalized Ribo-Seq for Quantifying Absolute Global and Specific Changes in Translation

Authors: Katharina Hoerth, Sonja Reitter and Johanna Schott, date: 02/20/2022, view: 1105, Q&A: 0

Ribosome profiling (Ribo-Seq) is a highly sensitive method to quantify ribosome occupancies along individual mRNAs on a genome-wide scale. Hereby, ribosome-protected fragments (= footprints) are generated by nuclease digestion, isolated, and ...

More >

COVID-19 Sample Pooling: From RNA Extraction to Quantitative Real-time RT-PCR

Authors: Kenny Voon, Nur Alia Johari, Khai Lone Lim, Siew Tung Wong, Loke Tim Khaw, Shew Fung Wong, Elaine W. L. Chan, Kok Keong Chan, Boon Keat Tan, Nurul Hanis Ramzi, Patricia K. C. Lim and Lokman H. Sulaiman, date: 05/05/2021, view: 6246, Q&A: 1

The COVID-19 pandemic requires mass screening to identify those infected for isolation and quarantine. Individually screening large populations for the novel pathogen, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is costly and

...

More >

More protocols >